![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](hb2782contents.gif)
Acta Cryst. (2008). E64, m1201-m1202 [ doi:10.1107/S1600536808026469 ]
2O3,O4)copper(II)]-
-1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylato-
3N7':O3,O4] tetrahydrate]Abstract: In the title compound, {[Cu(C16H17FN3O3)2]·4H2O}n, the CuII atom is bonded to two O,O'-bidentate 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylate (norf) monoanions and a symmetry-generated N-bonded norf anion, resulting in a distorted square-pyramidal coordination environment with the N atom occupying the apical site. The bridging norf anion results in one-dimensional chains propogating along [010]. A network of O-H
O and N-H
O hydrogen bonds helps to establish the crystal structure.
Online 23 August 2008
Copyright © International Union of Crystallography
IUCr Webmaster